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Objective. To determine if extra-peritoneal laparoscopic para-aortic (PA) lymphadenectomy allows a reliable assessment of PA nodes in
patients with endometrial cancer (EC).
Methods. In October of 2005, a single surgeon began performing extra-peritoneal laparoscopic PA lymphadenectomy for patients with EC. A
prospective cohort study was initiated from October 2005 through October 2007. Staging of Group A included extra-peritoneal laparoscopic PA
lymphadenectomy, while Group B underwent staging via laparotomy.
Results. In a 24 month period, 293 patients underwent surgical treatment for EC, 203 of them underwent complete staging as determined by
previously published criteria. Extra-peritoneal laparoscopic PA lymphadenectomy to the renal veins was successful in 35/38 patients (92%). Mean
BMI was 33.0 for Group A and 32.3 for Group B (p=NS). Mean EBL and hospital stay were lower in Group A compared to Group B (163 vs
373 cm3, pb0.0001; median 2 vs 4 nights, pb0.001). The total number of PA nodes harvested was not statistically different between Groups A
and B (16.5 vs 19.6). Interestingly, in Group A the total number of PA nodes was greater for patients with BMIN35, (21.6 vs 13.1), while in Group
B fewer nodes were removed in obese patients (17.8 vs 20.5).
Conclusions. Extra-peritoneal laparoscopy is a reliable method to routinely reach the level of the renal veins, even in obese patients. This
approach was feasible in over 90% of unselected patients and well-tolerated.
© 2008 Elsevier Inc. All rights reserved.Keywords: Endometrial carcinoma; Laparoscopy; LymphadenectomyIntroduction
We believe that adequate assessment of lymphatic spread in
patients with endometrial cancer requires resection of all nodal
tissue at risk. This includes assessment of para-aortic (PA)
lymph nodes above the inferior mesenteric artery (IMA) up to
the level of the renal veins. In support of this, a recent
prospective investigation demonstrated that 77% of patients
with PA metastases harbor disease above the IMA [1].
Furthermore, in 60% of these patients ipsilateral PA nodes
below the IMAwere free of disease. Thorough staging results in
accurate documentation of disease spread, may act as a
therapeutic intervention [2–4], and helps determine the need⁎ Corresponding author. 200 1st Street NW, Rochester, MN 55905, USA. Fax:
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doi:10.1016/j.ygyno.2008.08.021for and extent of post-operative radiation therapy. Documenta-
tion of the status of the PA nodes is particularly important given
that 47% of patients with metastatic pelvic nodes will either
have positive PA nodes or will subsequently recur in the PA area
[5]. With the exception of patients at risk for vaginal recurrence
who receive vaginal brachytherapy alone, it is not our practice
to prescribe adjuvant radiotherapy for patients with negative
lymph nodes [6]. Given the key role of systematic lymphade-
nectomy in our treatment algorithm, it was paramount that the
completeness of lymph node assessment not be compromised
when laparoscopic lymphadenectomy was introduced into our
practice.
The adequacy of laparoscopic pelvic lymphadenectomy has
been well-documented [7–9]. Laparoscopic PA lymphadenect-
omy to the level of the IMA is also successful in most patients.
In contrast, routine extirpation of all PA lymph nodes to the
level of the renal veins may be exceedingly difficult
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performed by the GOG, 23% of patients with endometrial
cancer randomized to laparoscopy required laparotomy in order
to complete the staging [11]. Reasons for conversion included
poor exposure [12]. We found this observation problematic
given the high frequency of obesity in patients with endometrial
cancer together with our recent data demonstrating that stopping
the dissection at the level of the IMA will routinely miss 38–
46% of patients with metastatic PA nodes [1]. Consistent with
this observation, there is at least one report of a PA recurrence
above the IMA following a laparoscopic infra-mesenteric PA
dissection [13].
After evaluation of various techniques, we hypothesized that
the extra-peritoneal approach would offer the greatest consis-
tency in lymphatic assessment regardless of patient BMI, and it
was this approach that was adopted [14–22]. This technique has
been utilized previously for patients with cervical carcinoma to
minimize the development of adhesions and potentially reduce
the risk of radiation-related complications [23,24]. Since the
entire dissection is limited to the retroperitoneum, an additional
advantage of this approach is that difficulties with exposure
resulting from overlying small bowel loops or obesity are
reduced. Here we prospectively assess the first two years of our
experience with extra-peritoneal laparoscopic para-aortic lym-
phadenectomy, specifically examining the thoroughness of the
nodal dissection with respect to the IMA in comparison to
patients who underwent staging via laparotomy. The surgical
technique is also described.
Patients and methods
In October of 2005, laparoscopic pelvic and para-aortic
lymphadenectomy was incorporated into the surgical manage-
ment algorithm of endometrial carcinoma at Mayo Clinic,
Rochester, MN. This included routine use of the extra-
peritoneal approach for laparoscopic para-aortic lymphadenect-Fig. 1. Schematic illustrating port placement in the left flank. The lowermost port (1
superior to, the left anterior superior iliac spine. The remaining trocars are triangulated
10 mm. The third, most cephalad 5 mm trocar is located just inferior to the costal momy. Corresponding with this practice change, demographic,
intra-operative, and post-operative data from all patients with
primary endometrial carcinoma who were surgically managed
from October 2005 to October 2007 were collected in a
prospective fashion. All patients were operated on by a
gynecologic oncologist, with a single surgeon (SCD) perform-
ing all laparoscopic procedures.
As previously reported we use objective criteria to determine
the need for lymphadenectomy at our institution and approxi-
mately 27% of patients will not require lymphadenectomy [25].
Thus, patients were either treated with hysterectomy alone
(vaginal or abdominal), hysterectomy (vaginal or laparoscopic)
and laparoscopic pelvic and para-aortic lymphadenectomy, or
hysterectomy and open pelvic and para-aortic lymphadenect-
omy. Given savings in cost, operating times, and low morbidity,
we prefer the transvaginal route if feasible rather than the
laparoscopic-assisted vaginal technique for the 27% of patients
who require hysterectomy only.
For patients whose tumor characteristics warrant assessment
of lymph nodes, a systematic pelvic and para-aortic lympha-
denectomy (not sampling) was routinely performed. Details of
the pelvic and para-aortic lymphadenectomy via laparotomy
have been previously described [1]. Briefly, pelvic lymphade-
nectomy consisted of complete skeletonization of the common,
external, and internal iliac vessels and harvesting of all fatty and
lymphatic tissue above and below the obturator nerve. After
mobilization of the ascending and descending colon, all
lymphatic tissue was harvested from the lateral, anterior, and
medial aspects of the vena cava and aorta to the level of the
renal veins. For the purposes of this investigation and an
ongoing outcomes analysis, our current surgical algorithm
includes histologic assessment of para-aortic lymph nodes
according to their position relative to the level of the inferior
mesenteric artery (IMA). Thus, tissue removed between the
renal vein and the IMA is identified separately from tissue
removed between the IMA and aortic bifurcation.0 mm) is located two fingerbreadths medial to, and three to six fingerbreadths
one finger's length from the initial incision. The second, more posterior trocar is
argin.
Table 1
Characteristics of patients referred to the surgeon performing laparoscopy vs all
others
Characteristic Potential scope Laparotomy p
valuen (%) n (%)
Age (mean) 68 64.4 NS
BMI (mean) 33.3 33.0 NS
Tumor grade
1/2 26 (65) 98 (60) NS
3 14 (35) 64 (40) NS
Stage
IA 7 (13) 44 (18) NS
IB 26 (50) 120 (50) NS
IC 11 (21) 20 (8) 0.01
II 3 (6) 2 (1) NS
IIIA 1 (2) 12 (5) NS
IIIC 4 (8) 24 (10) NS
IV – 19 (8) 0.04
Histological subtype
Endometrioid 44 (85) 183 (76) NS
UPSC 7 (13) 49 (20) NS
Clear cell 1 (2) 7 (3) NS
MMMT – 1 (0.5) NS
Neuroendocrine – 1 (0.5) NS
BMI, body mass index; NS, not statistically significant; UPSC, uterine papillary
serous carcinoma; MMT, malignant mixed müllerian tumor.
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transperitoneal inspection of the abdomen to search for
metastatic disease through an umbilical port. In the absence of
extrauterine disease a 2 cm incision was made two finger-
breadths medial to, and three to six fingerbreadths superior to,
the left anterior superior iliac spine (Fig. 1). The fibers of the
underlying obliques and transversalis muscles were then split
until the peritoneum itself was identified. The retroperitoneal
space beneath the transversalis muscle was developed poster-
iorly until the left psoas muscle was palpated. A 10-mm trocar
was then positioned in the left flank and the retroperitoneal
space insufflated. Additional blunt dissection was then
performed utilizing the index finger in the first incision and
the laparoscope within the port until the psoas muscle was
readily visualized. A 5-mm trocar was then placed under direct
visualization and a third trocar placed in the initial incision.
Proper placement of these three ports is crucial. Improper
placement will handicap the ability of the surgeon to operate in
this relatively tight area, or else result in perforation of the
peritoneum, making this approach difficult or impossible. Initial
insufflation pressures (10 mm Hg) and flow rates (3 L/min) are
low in order to minimize the risk of peritoneal perforation, and
theoretically reduce the risk of pneumothorax and hypercarbia.
If additional exposure is necessary the pressure can be gradually
increased, although 15 mm Hg is rarely necessary. Emphysema
is commonly noted in the mesentery of the sigmoid colon.
However, when the lowermost left flank trocar is converted to
an intraperitoneal position for transperitoneal pelvic lympha-
denectomy, this emphysema rapidly dissipates and does not
interfere with subsequent intraperitoneal procedures.
The left ureter and adjacent gonadal vessels are readily
identified just medial to the psoas muscle and allowed to retract
anteriorly and out of the field by the pressure of insufflation. The
dissection is continued medially until the left common iliac artery
and aorta are identified. The gonadal vein is followed superiorly
into the left renal vein. At this point all critical anatomy has been
identified and the para-aortic nodes between the aortic bifurcation
and left renal vein are removed. To remove the right para-aortic
nodes, the dissection is continued medially over the aorta and
down to the inferior vena cava (IVC). The space between the IVC
and lymph nodes is developed on each side of the preserved IMA
allowing the nodes to retract anteriorly with the pressure of
insufflation in a similar manner as the left ureter. Although not
necessary, the right ureter can be identified just lateral to the
dissection. Once isolated from the underlying IVC, the right para-
aortic nodes are then stripped from the anterior peritoneum, or
“roof” of the dissection. After the nodes are removed, the
lowermost trocar may be converted to an intraperitoneal position
(achieved simply by advancing this trocar through the perito-
neum) to be used for the transperitoneal pelvic lymphadenectomy.
Thus, a total of 6 trocar incisions are used: three in the left flank
(for para-aortic lymphadenectomy, the lowermost left flank trocar
is also used for pelvic lymphadenectomy), one in the umbilicus,
one in the suprapubic position, and one in the right lower quadrant
(for pelvic lymphadenectomy). Operating times for laparoscopic
para-aortic lymphadenectomy were determined from video
recordings made from each procedure.Statistical analyses were performed with Fisher's exact tests
to evaluate the relationship between pairs of categorical
variables. Mann–Whitney U test was used to test for differences
between groups in the distributions of continuous measures.
Differences between groups were considered statistically
significant at pb0.05. JMP statistical program (version 4.0.4,
SAS Institute, Inc., Cray, North Carolina) was used for the
analysis. This investigation was approved by the Institutional
Review Board of Mayo Foundation. In accordance with the
Minnesota Statute for Use of Medical Information in Research,
only those patients who consented to the use of their medical
records were included in this analysis.
Results
In order to reveal any potential selection or referral biases,
two comparisons were made between four cohorts of patients.
The first two cohorts discussed initially include all patients
referred to the surgeon performing laparoscopy (potential
candidates for laparoscopic staging) vs all other patients.
Succeeding paragraphs consider only those patients in whom
extra-peritoneal laparoscopic para-aortic lymphadenectomy
was performed (Group A) vs those patients who underwent
para-aortic lymphadenectomy via laparotomy (Group B).
In a 24 month period, 293 patients underwent primary
surgical treatment for endometrial cancer. Fifty-two patients
were referred to the surgeon performing laparoscopic staging
and were all initially considered as potential candidates for
laparoscopic surgery. The remaining 241 patients were
counseled regarding staging by laparotomy, if required,
according to protocol. Baseline patient characteristics are
shown in Table 1. The laparotomy group included a smaller
proportion of patients with stage IC and a larger proportion of
421S.C. Dowdy et al. / Gynecologic Oncology 111 (2008) 418–424patients with stage IV disease. Otherwise, no differences were
noted with respect to age, BMI, histology, or proportion with
positive nodes (stage IIIC).
Staging lymphadenectomy was performed in 203 patients as
determined by previously published criteria. For the cohort
referred to the surgeon performing laparoscopy, 41 (79%) were
staged compared to 162 (67%) in the laparotomy group.
Excluding the four patients referred for laparoscopic staging
after hysterectomy elsewhere, 71% in the former cohort were
staged (p=NS).
Of the 52 patients considered for laparoscopic lymphade-
nectomy, in most cases hysterectomy was performed vaginally
without the need for laparoscopic assistance. In the event that
the tumor characteristics warranted lymphatic assessment, the
patient was then repositioned for laparoscopic staging. Ten
patients did not meet criteria for staging and underwent
hysterectomy only (9 vaginal, 1 abdominal). Complete staging
was performed in 41 patients, 35 via extra-peritoneal laparo-
scopy, 1 via transperitoneal laparoscopy, and 5 via laparotomy.
Protocol was breached in 1 (2%) 85 year old patient with
multiple co-morbidities and only 3 mm invasion who under-
went vaginal hysterectomy, bilateral salpingo-oophorectomy,
and laparoscopic pelvic lymphadenectomy only. Thus, 6 (12%)
patients had an open procedure, four of which were planned
(discussed further below). Extra-peritoneal PA dissection was
unsuccessful in three patients because of perforation of the
peritoneum: 2 were performed via laparotomy (BMI 51.5 and
37) and 1 via transperitoneal laparoscopy. Thus the extra-
peritoneal approach was successful in 35 of 38 patients (92%)
requiring staging by protocol. The 4 patients who underwent a
planned open procedure are described in Table 2. In three of
these four patients, laparotomy was planned because the uterus
was felt to be too large to be removed without morcellation and/
or there was a suspicion of advanced disease. In a fourth patient
the laparoscopic approach was considered unwise because of
multiple previous surgeries, including a renal transplant.
Remaining analyses will be limited to patients who under-
went lymphadenectomy. Group A includes the 35 patients who
underwent laparoscopic extra-peritoneal para-aortic lymphade-
nectomy, Group B the 167 patients who underwent lymphade-
nectomy via laparotomy (the single transperitoneal laparoscopic
PA lymphadenectomy was eliminated from analysis). Mean
BMI was 33.0 (range 21.6–51.6) and 32.3 (range 16.4–58) for
Groups A and B, respectively (p=NS).Table 2
Characteristics of patients who were considered for laparoscopy, but underwent plan
Patient BMI Procedure Uterine w
(g)
1 58 TAH, BSO, PPALND, panniculectomy, hernia repair 885
2 30 Radical hysterectomy, BSO, PPALND 720
3 40 Radical hysterectomy, BSO, PPALND, omentectomy 335
4 a 48 TAH, BSO 230
BMI, body mass index; TAH, trans-abdominal hysterectomy; BSO, bilateral salping
malignant mixed müllerian tumor; UPSC, uterine papillary serous carcinoma.
a Tumor characteristics did not meet criteria for lymphadenectomy.As described above, in three patients the extra-peritoneal
approach was unsuccessful after the peritoneum was perforated
during port placement (1 managed with transperitoneal para-
aortic lymphadenectomy, the other two via laparotomy). No
conversions were performed for hemorrhage and no other intra-
operative complications occurred which were related to the
extra-peritoneal para-aortic lymphadenectomy. Mean EBL for
the entire procedure (hysterectomy and lymphadenectomy) was
163 cm3 for the laparoscopic group compared to 373 cm3 for
Group B (pb0.0001). Only 1 patient in Group Awas transfused,
but her hemoglobin increased from 7.6 to 11.8 after receiving 2
units of packed red blood cells in the recovery room. It may be
that the pre-transfusion value was obtained from a blood draw
proximal to intravenous administration of crystalloid.
There were 3 (6%) post-operative complications in Group A.
A 78 year old developed post-operative atrial fibrillation re-
sulting in an 8 day admission. She was later readmitted after
being over-anticoagulated and noted to have a retroperitoneal
hematoma managed with 2 units of packed red blood cells. The
post-operative course of a 93 year old was complicated by
delirium which required a 6 day hospitalization. Ischemic
brain injury was ruled out and the delirium resolved prior to
discharge. A third patient underwent a concurrent sling
placement for urinary incontinence. She developed a urinary
tract infection and adynamic ileus and was hospitalized for 5
days. Although imaging was not performed specifically to
search for lymphocysts in the PA area, if present, none were
symptomatic.
Median operating time for the extra-peritoneal laparoscopic
para-aortic lymphadenectomy was 69 min (range 20–121). The
20 minute case involved a patient with an extensive anomalous
network of left renal vessels which resulted in an abbreviated
dissection. The next fastest operating time was 48 min.
Operating times were noted to improve with additional
experience. The first 10 cases lasted a median of 84.8 min vs
66.8 min for the remaining 25 cases (p=0.03). Operating times
for para-aortic lymphadenectomy via laparotomy were not
recorded separately from the overall operating time prohibiting
a direct comparison between groups. There was no correlation
between BMI and operating times in the laparoscopic group.
As shown in Table 3, the total number of para-aortic lymph
nodes harvested was not statistically different between groups.
Furthermore, no differences in the number of lymph nodes were
noted when stratified with respect to location above or belowned laparotomy for endometrial cancer
eight Stage Histology Other
IC Endometrioid Huge ventral hernia
IIIC MMMT Suspicion of cervical involvement (confirmed)
IIB UPSC Suspicion of cervical involvement (confirmed)
IB Endometrioid Previous renal transplant
o-oophorectomy; PPALND, pelvic and para-aortic lymphadenectomy; MMMT,
Table 3
Para-aortic node counts in patients staged via extra-peritoneal laparoscopy vs




Total nodes 16.5 19.6
BMIb35 13.1⁎^ 20.5^
BMI≥35 21.6⁎ 17.8
Above IMA 9.5 11.3
BMIb35 7.4⁎^ 12.2^#
BMI≥35 12.3⁎ 9.7#
Below IMA 7.9 8.5
BMIb35 6.2⁎^ 8.9^
BMI≥35 10.2⁎ 7.8
⁎, ^, and # indicate pairs within each subset that are statistically different.
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data was stratified by BMIN35. Laparotomy resulted in higher
para-aortic node counts than laparoscopy for non-obese
patients, while the opposite was true for obese patients,
although this trend was not statistically significant (Table 3).
A trend of improving node counts with additional experience
could not be demonstrated.
Median hospital stay was 2 nights for those in Group A
(staged laparoscopically) vs 4 nights for those in Group B
(pb0.001). For patients not requiring staging, median hospital
stay was 3 nights for those who underwent trans-abdominal
hysterectomy and bilateral salpingo-oophorectomy vs 2 nights
for those who underwent vaginal hysterectomy and bilateral
salpingo-oophorectomy only. For Group A, age N70 was
associated with longer hospital stay, mean 3.7 vs 2.1 nights
(pb0.001). Similarly, for the 5 patients who were dismissed
within 24 h, their mean age was 63 vs 77 for the 8 patients with
5–8 day admissions (p=0.01). For Group B, age had no effect
on hospital stay (5.3 vs 5.6 nights). BMI had no impact on
hospital stay for Group A, while this was of borderline
significance in Group B (5.2 vs 6.5 nights for BMIN35,
p=0.059).
Longest follow-up was 2 years, prohibiting a valid survival
analysis. However, only 1 patient from the laparoscopic cohort
has recurred, a patient with a grade 3, stage IIIA tumor with
full thickness myometrial invasion. Post-operatively she was
treated with pelvic radiation. Chemotherapy with IV carbo-
platin and paclitaxel was discontinued after she developed
neutropenic sepsis. Her isolated central recurrence occurred 12
months after primary surgery and was managed with posterior
exenteration at the time of preparation of this manuscript. She
is scheduled to receive single agent carboplatin at a dose
reduction.
Discussion
Through the pioneering efforts of surgeons in this country
and across Europe, the widespread adoption of laparoscopic
surgery represents perhaps one of the most significant changes
in the surgical aspect of gynecologic oncology. However, the
utilization of laparoscopy for patients with endometrial cancer is
accompanied by unique challenges given its known associationwith obesity. While laparoscopic surgery in obese patients can
be time consuming and extremely difficult, we must accept that
most patients with endometrial cancer are obese, and we are
therefore obliged to devise techniques to provide obese patients
with the same standards of care as patients who are thin.
Previous publications investigating the use of laparoscopic
transperitoneal para-aortic lymphadenectomy for patients with
endometrial cancer have identified potential shortcomings of
this approach. For example, in a review of 206 patients with a
BMIN35 with endometrial cancer, the median number of para-
aortic nodes removed in the transperitoneal laparoscopic cohort
was only 6 [10]. Such a result from an institution known for
their surgical expertise suggests an inherent weakness not in the
surgeon, but in the procedure itself. Perhaps because of these
very constraints, there is evidence that utilization of transper-
itoneal laparoscopy for endometrial cancer staging is limited
outside of tertiary care institutions. In a review of over 12,000
patients from two California databases, Leiserowitz, et al.
demonstrated that patients who underwent laparoscopic proce-
dures for endometrial cancer were younger and had signifi-
cantly fewer comorbid conditions than did those who
underwent laparotomy [26]. Patients who underwent laparo-
scopy were also much less likely to be obese. Thus, the use of
transperitoneal laparoscopic staging appears to be limited to the
most favorable operative candidates at the present time. It is
unfortunate that the benefits of minimally invasive surgery
cannot be more consistently applied to the cohort of patients
with the most potential to benefit.
In the present study we failed to demonstrate any
differences in patient demographics, including BMI, between
groups. All patients with endometrial cancer referred to the
laparoscopic surgeon were reported and only 4 patients (8%)
underwent a planned open procedure, all for valid reasons
(Table 2). Despite this, there were no differences in para-
aortic lymph node counts between groups. Although para-
aortic node counts were somewhat higher in the laparoscopic
cohort for patients with BMIN35, this finding is likely to be
spurious due to the relatively small size of the laparoscopic
cohort. Alternatively, lymphadenectomy via laparotomy was
superior for patients with BMIb35, but these differences do
not appear to be clinically relevant given that assessments by
both approaches were quite thorough. Overall, these data
support the conclusion that the laparoscopic extra-peritoneal
para-aortic approach is at least equivalent to assessment via
laparotomy in the average, and particularly in the obese,
patient. This is also indirectly supported by a lack of a
correlation between operative times and BMI. That PA
lymphadenectomy can be performed safely and thoroughly,
even in the most obese patients using this technique is
noteworthy. In the most obese patient of this series to
undergo laparoscopic PA lymphadenectomy (BMI 51.6), 34
para-aortic nodes were harvested, 21 of which were located
above the IMA.
We demonstrate that the laparoscopic extra-peritoneal
approach is successful in 92% of patients. No patient was
considered ineligible for laparoscopy based on weight or
comorbid conditions alone. In experienced hands this
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operations to be performed by this surgeon. A similarly high
success rate has also been demonstrated by other groups in both
endometrial and cervical cancer [17,18]. Infrequent complica-
tions were minor and not specific to the technique described
here. Significant improvements in estimated blood loss and
hospital stay compared to the laparotomy group were also
observed. These findings are consistent with those described by
the GOG in their randomized trial [11]. Thus, the advantages
demonstrated for transperitoneal laparoscopy appear to apply
also to the extra-peritoneal approach. The maturity of our data is
at present not adequate to perform an outcomes comparison.
The extra-peritoneal approach may offer more advantages
than just exposure in obese patients. Lowe, et al. demon-
strated the feasibility of teaching this technique to fellows
[27]. Another important advantage is that in contrast to
transperitoneal para-aortic lymphadenectomy, extra-peritoneal
laparoscopy requires no expert assistance. Only three ports
are used, such that the first assistance is required only to
direct the optic.
A disadvantage of extra-peritoneal laparoscopy is that it is not
widely utilized in the United States and instruction is currently
limited. The reluctance to utilize this procedure may be due to a
lack of familiarity with the extra-peritoneal approach itself.
Surgeons with past experience in extra-peritoneal laparotomy to
remove para-aortic nodes from patients with advanced cervical
cancer may be confident enough to attempt this technique
without specific training. An additional disadvantage is that the
integrity of the peritoneum must be preserved. In the event that
the peritoneum is perforated, the advantage provided by the
extra-peritoneal pneumoperitoneum in terms of exposure and
retraction is lost. It is possible, however, to tamponade small
peritoneal defects using a Foley catheter balloon, if they do
occur. The Foley catheter is advanced directly through the skin
and peritoneal defect after removing the port. This is facilitated
by transperitoneal visualization using an umbilical port. The
catheter is then inflated, placed on traction, and the port replaced
immediately adjacent to the Foley.
This investigation was not designed to directly compare
transperitoneal and extra-peritoneal laparoscopy and is not
intended to suggest superiority of one approach over another.
But our data do suggest that extra-peritoneal laparoscopy may
have advantages, particularly in obese patients, given the ease
of reaching the renal veins. While we believe that dissection up
to the renal veins is prudent and necessary in patients that
require lymphadenectomy, this investigation was not intended
to support this concept.
Although this investigation was prospective and included a
relatively large number of patients, several shortcomings and
potential biases exist. All laparoscopic procedures were
performed by a single surgeon and these results must be
replicated by others before they may be extrapolated to other
practices. However, it should be pointed out that these data
represent the very first patients to undergo laparoscopic
lymphadenectomy by this surgeon, supporting the notion that
these results should easily be attained by others. Although the
total number of patients was relatively large, only 35 patientsunderwent extra-peritoneal para-aortic lymphadenectomy, sug-
gesting expansion of this cohort followed by further analysis to
confirm our present findings.
This investigation was non-randomized. While referral bias
is a potential source of confounding, this effect should be
relatively minor in our practice. Referrals to our division are
handled by a central appointment desk that makes assignments
according to availability rather than seniority to ensure equitable
distribution of cases and patient access. Furthermore, analysis
of patient and tumor characteristics showed no significant
differences between groups with regard to age, histologic
subtype, or BMI. Stage distribution was also very similar,
although the laparoscopic group had a higher proportion with
stage IC disease, and a lower proportion with stage IV disease.
This finding may be sporadic given the small number of patients
in these groups.
In conclusion, extra-peritoneal laparoscopy is an easily
learned technique which may have advantages over transper-
itoneal laparoscopy for assessment of the para-aortic lymph
nodes in patients with endometrial cancer. These advantages
appear to be particularly apparent in patients with BMIN35.
Average operating time was just over one hour, and was not
correlated with BMI. No intra-operative complications
occurred in this series. Extra-peritoneal laparoscopy has the
same benefits as traditional laparoscopy in regards to blood
loss and post-operative recovery. For gynecologic oncologists
who believe in the importance of complete para-aortic
assessment, the extra-peritoneal approach is a feasible option.
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